Pravastatin Sodium tablets recalled for manufacturing practice violations
Accord Healthcare is recalling Pravastatin Sodium 20 mg tablets following an FDA inspection that identified manufacturing practice deviations. Approximately 32,688 bottles were distributed in the United States, Puerto Rico, and Canada.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving manufacturing practice deviations found during an FDA inspection. While no illnesses or injuries have been reported, CGMP violations represent a real quality and safety risk in a pharmaceutical product requiring mandatory action.
Plain-English summary
Accord Healthcare, Inc. is recalling Pravastatin Sodium Tablets USP 20 mg in 90-count bottles due to Current Good Manufacturing Practice (CGMP) deviations discovered during an FDA inspection. The affected product has NDC 16729-009-15 and affected batch numbers are R2200589, R2200689, R2200690, and R2201232, all with an expiration date of April 30, 2024.
Approximately 32,688 bottles have been distributed in the United States, including Puerto Rico, and Canada. The product is manufactured by Intas Pharmaceuticals Limited in Ahmedabad, India, for Accord Healthcare, Inc., of Durham, North Carolina.
The FDA classifies this recall as a Class II recall. No illnesses or injuries related to the recalled tablets have been reported as of the time of this recall notice.
Patients taking these tablets should contact their pharmacy or healthcare provider for guidance regarding their treatment. Unused tablets should be properly disposed of through a pharmacy or following FDA disposal guidelines.
The recalled product
- Product
- PRAVASTATIN SODIUM (PRAVASTATIN SODIUM)
- Brand
- PRAVASTATIN SODIUM
- Manufacturer
- Accord Healthcare, Inc.
- Category
- Drug — Oral Tablet
- Hazard
- Affected units
- 32,688
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Batches: a )R2200589
- R2200689
- R2200690
- R2201232
- Exp. Date 4/30/2024
UPCs (1)
- 316729009157
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 67 recalled by Accord Healthcare, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 67 products in this recall →Related recalls
Same brand · PRAVASTATIN SODIUM
- ModeratePravastatin Sodium Tablets Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2025-04-16
- ModeratePravastatin Sodium Tablets Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2025-04-16
- ModeratePravastatin Sodium 20mg Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2025-04-16
- ModerateGlenmark Pharmaceuticals Recalls Pravastatin Sodium Tablets 80mg
FDA (Drugs) · 2025-04-16
- HighPravastatin Sodium Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2024-07-24
Same manufacturer · Accord Healthcare, Inc.
See all →- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
Same hazard · manufacturing defect
See all →- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-09-02
- HighSun Pharmaceutical Recalls Carbamazepine Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2026-08-26
- HighU2 Total Knee System Femoral Valgus Adaptor Recall
FDA (Devices) · 2026-08-12
- HighUnited Orthopedic Corp. Recalls Femoral Valgus Offset Adaptors for U2 Total Knee System
FDA (Devices) · 2026-08-12
- HighKnee Prosthesis Trial Recall for Manufacturing Defect
FDA (Devices) · 2026-08-12